WASHINGTON, Aug. 14 -- Health Resources and Services Administration has issued a notice called: Notice With Request for Comment: Consideration of Adding Metachromatic Leukodystrophy to the Recommended Uniform Screening Panel.
The notice was published in the Federal Register on Aug. 14 by Maria G. Button, Director, Executive Secretariat.
Summary: HRSA is considering recommending to the Secretary the addition of Metachromatic Leukodystrophy (MLD) to the Recommended Uniform Screening Panel (RUSP). HRSA is providing notice and requesting comments from the public on this potential recommendation. Conditions listed on the RUSP are part of the evidence-informed preventive health guidelines supported by HRSA for infants and children. Non-grandfat...